BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Metabolism of xenobiotics
,
Arthritis
,
Hypothalamus
,
Hematopoietic cell
,
Bleomycin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
pertuzumab
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
KLK11
ANPEP
FBLN1
TGFBI
ALPK2
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_UP
CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN
NUYTTEN_EZH2_TARGETS_UP
LIM_MAMMARY_STEM_CELL_DN
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
Ovarian cancer SCOV3 cell xenografts from mice treated with trastuzumab and pertuzumab
Explore Curated Studies Results
Literature
Most Relevant Literature
Mass Spectrometric ITEM-ONE and ITEM-TWO Analyses Confirm and Refine an Assembled Epitope of an Anti…
First-in-Human Evaluation of Site-Specifically Labeled 89Zr-Pertuzumab in Patients with HER2-Positiv…
Combined physicochemical and functional assessment of pertuzumab integrity supports extended in-use …
Exploring the Combined Action of Adding Pertuzumab to Branded Trastuzumab versus Trastuzumab Biosimi…
A disproportionality analysis of adverse events associated to pertuzumab in the FDA Adverse Event Re…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Phase III Trial of Pertuzumab Retreatment in Previously Pertuzumab Treated Her2-Positive Advanced …
Pyrotinib Plus Trastuzumab Versus Pertuzumab Plus Trastuzumab
Atezolizumab + Pertuzumab + Trastuzumab In CNS Mets In BC
Trastuzumab & Pertuzumab Followed by T-DM1 in MBC
A Safety and Efficacy Extension Study of Pertuzumab in Patients With Solid Tumors Previously Enrolle…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ